HFA Premium Access

Diuretic dose is a strong prognostic factor in ambulatory patients awaiting heart transplantation.

Congress Presentation

About the speaker

Doctor Guillaume Baudry

University Hospital of Brabois , Nancy (France)
1 presentation
0 follower

6 more presentations in this session

Pharmacologic transition in the care of patients with heart failure with reduced ejection fraction - a real life analysis

Speaker: Doctor I. Cruz (Penafiel, PT)

Thumbnail

Assessing the achievability of optimal therapy in patients with heart failure with reduced ejection fraction; a difficult task?

Speaker: Miss F. Bernier (Quebec, CA)

Thumbnail

Risk of safety events considered potential barriers to utilization of guideline-directed medical therapy among patients with worsening heart failure and ejection fraction 30% or lower

Speaker: Doctor S. Greene (Durham, US)

Thumbnail

Clinical outcomes in patients with ischemic versus non-ischemic cardiomyopathy after angiotensin-neprilysin inhibition therapy

Speaker: Doctor C. Sabanoglu (Ankara, TR)

Thumbnail

Five-year retrospective analysis of treatment efficacy effectiveness of sacubitril/valsartan in heart failure with reduced ejection fraction with end-stage renal disease

Speaker: Doctor B. Hsiao (Taipei, TW)

Thumbnail

Access the full session

Chronic heart failure - pharmacotherapy 1

Speakers: Doctor G. Baudry, Doctor I. Cruz, Miss F. Bernier, Doctor S. Greene, Doctor C. Sabanoglu...
Thumbnail

About the event

Image

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb